chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 20 minutes of my first dose I had a bad headache and felt sick on my stomach. I ended up with pneumonia I was so sick that day I couldn't go. I got progressively got worse. I don't remember how soon after I went to the doctor.  Before I went to the doctor I went to the ER then I went to Medical Clinic 5/21/2021 I still continue to have problems with my lungs and have to use inhalers  I was prescribed z-pack 250mg, cough medicine Mucinex, Cheratussin, and Tamiflu 2 inhalers albuterol and another I don't know the name of, Prednisone, Cetirizine 10MG,
Developed rash on hands, arms, feet, legs, back and lips consistent with Erythema Multiforme (diagnosed by dermatology), associated with swelling of hands, knees and ankles.  Exam findings: Lower lip diffusely edematous with superficial desquamation -Remainder of oral and ocular mucosa normal appearing -Bilateral arms, dorsal hands/palms, lower extremities, dorsal feet discrete classic targetoid erythematous plaques, some with central vesicles and coalescing broad annular erythematous plaques with central clearing/hyperpigmentation  Treated with Triamcinolone 0.1% ointment to body and hydrocortisone 2.5% ointment to lip twice daily and Zyrtec Symptoms resolved over 1-2 weeks
Vomiting & shaking with chills overnight; whole upper arm red and swollen for 4+ days; body aches after 24 hours of shot lasting 8 hours
Hives and rash developed over body. Hands and feet developed a shingles like pain. Could barely walk or touch anything with out severe pain. All the skin on hands and feet peeled off. Very, very painful.
PUI had some pre-existing medical conditions and when tested at hospital he was admitted and given Covid-19 treatment for 5 days. Patient is fully vaccinated.
Bells Palsy - Complete Paralysis of Left Side of Face occuring four days after injection.
9/20/05-Received TD vaccine (lot #U1597AA) 10/3/05-Received vaccines listed in box 14 below.  10/4/05-Dizziness lasting 24 hours. 11/7/05-Received vaccines listed in box 13 below. 11/8/05-Dizziness, hallucinations and disorientation lasting for 24 hours. She was seen by PMD and endocrinologist who suggested this was probably due to low blood sugar and not vaccine related.  In April or May of 2006, had a cognitive decline that was not gradual. She regressed and was unable to perform ADL's including dressing and feeding self and had mental slowing. She was evaluated at a Hospital  and in her home country. On 11-17--06 diagnositc impression was encephalopathy that affects the basal gangalion. She will be evaluated at a Clinic on Jan. of 2007. She is improved, but still not able to articulate well and appears slow to process information.  1/2/07 Received medical records from hospital which reveal patient seen in Memory & Cognitive disorders clinic on 7/18/06. HPI: indicates that symproms started 9/05 with unexplained weight loss of about 12 lbs; 10/05 a series of syncopal episodes; 1/06 allodynia, fatigue & malaise, restless leg syndrome;  The consult notes that symptoms started in 9/05 after received vax for a trip to Africa which did not occur.  Developed memory & cognitive problems with an abrupt onset in May/06 with panic type symptoms & insomnia.  Had a recent ear infection & resultant bells ringing in ears.  ALso headaches, trouble walking, weakness, shaking & dizziness.  Neuropsychological exam:  testing at another facility revealed frontal lobe dysfunction w/variable memory problems.  Testing at current hospital also revealed inconsistencies & was unable to provide a Final Dx. Patient out of country 7/19/06 & was to return to US 11 or 12/06.  Further f/u was to be done in foreign country. 1/29/07 Received medical records from Clinic which reveal patient evaluated on 1/8/07 for sudden memory loss, insult to brain & lack of equilibrium/balance since 5/06.  Records from a foreign university  where patient had been evaluated for dementia & records from 1st hospital clinic were reviewed. 1/06 patient dx by rheumatologist with reactive arthritis.  Had pain, nausea, insomnia, burning sensations of legs/feetanxiety attaches which were severe enough to cause patient to go to ER x3.  All symptoms except short term memory loss resolved.  Exam was notable for decreased visual & verbal interaction, hypophonic speech & tendency toward mask like facies.  Impaired smooth pursuits throughout but no cogwheel rigidity or resting tremor.   FINAL DX: Possible static encephalopathy secondary to YF vax. Repeat MRI requested & repeat neuropsychiatric testing to look for possible progressive cognitive inefficiencies.   Additional specialty consultation was requested.  Possible spongiform encephalitis & EEG was ordered to look for rhythmic discharges.
Noticed sore arm in side where vaccine was received.  Also noted swollen lymph node in axilla on side where vaccine was received.  No redness noted but visibly swollen and tender to touch.   Lymph decreased in size in approximately 3 days but did not completely go away until 3 weeks.
pt diagnosed positive for COVID on 8/14/21 by PCP; presents to ED with c/o increasing SOB and decreased O2 sats (76% on NRB); hx of COPD, multiple myloma; treated with antibiotics, steroids, anticoagulants, remdisivir; placed on BiPAP; eventually required intubation due to worsening condition; family decided on comfort care measures; pt was extubated and died at the hosp
redness, inderation at site of pneumovax injection extending distally to elbow; pt treated for possible cellulitis with po abtx
Patient's spouse reported the patient noticed a rash 2 days (approx 52 hours) after his second shingrix shot near the site of administration. There was also a slight rash on the chest and back. No rash from first shingrix and no swelling or anaphyllaxis, Advised benadryl and 911 if swelling of face/lips began.
Vaccination administered after the 10 week refrigeration expiration date  Administered on 01/20/2023, expired in refrigerator on 12/20/2022.  Patient had no problems or symptoms after administration.  Administration of expired dose reported to Pfizer on 02/06/2023 , pending final determination of efficacy.
My brother received this vaccination and became ill shortly afterward and we assumed this was a natural reaction to the vaccine and it would pass. He was still sick 10 days afterward and he went to a local urgent care who ordered a chest xray and gave him doxycycline. He felt better a few days after this antibiotic was finished but continued to not feel right. He was seen by his doctor on the 1st of September and continued to go downhill with noexplanation, on the 15th, he told me he had choked on a meat chunk but showed me his lower legs which were very swollen, he was short of breath, and throwing up mucous. I wanted to take him to the hospital but he refused and went by himself the next day. At the hospital he was admitted on the 16th of September with elevated troponin and bmp and blood pressure along with high white count and tachycardia. His echo showed an ejection fraction of 20%. He called me on the 17th and wanted to leave but I asked him to stay and a few hours later the hospital called and told me he had been found blue in the floor and he had been intubated and moved to icu. On the 18th he was doing well on the vent and plans were to keep him on the vent a little longer. On the 19th of September I received the call from ICU that he had coded and they would do 2 more rounds of CPR and let him go. I feel that he probably may have had some heart problem with his blood pressure but that the Johnson and Johnson shot may have excerbated this as he had shown no signs of any of this before. I am unsure of the date of his shot but am sure it is on record with the Health Dept. as I have not found his paperwork yet.
pt w/known sz disorder, good control on Depakote-approx 2-3 hrs p/vax had lethargy, dec tone duration 30 mins suspected sz;
Patient was in her usual state of health until approximately two weeks prior to presentation when she developed chest pain that she describes as mid-sternal and 5/10 in severity. The pain is non-radiating, is worse with inspiration, and better with leaning forward. She presented to the ED the 11/24 and at that time was diagnosed with pericarditis and discharged with NSAIDs. She also began taking colchicine approximately one day prior to the current admission at the advice of her outpatient provider when symptoms failed to improve. As part of her follow up from ED discharge, she was scheduled for a TTE the day of admission where she was found to have a moderate circumferential pericardial effusion measuring 17 mm posteriorly with evidence of raised intrapericardial pressure (25% respiratory variation in the mitral Doppler spectral profiles) and no evidence of frank tamponade. Given the effusion, she was referred to the ED for further evaluation and subsequently admitted to cardiology for further management.
Information has been received from a nurse concerning a female who on unspecified date was vaccinated with her first dose of GARDASIL (lot#unspecified). Concomitant therapy included DEPAKOTE, ZOLOFT and PRILOSEC. On unspecified date the benzodiazepine drug test was performed. It was reported that the patient's benzodiazepine drug test came back positive even though she did not take any benzodiapine drugs. the only new drug that she received prior to the test was the first dose of GARDASIL. She has not yet received the second dose. Unspecified medical attention was sought in physician's office. No further information is available. Additional information has been requested.
I was given the covid 19 immunization with out the diluent. so I was told I given the 2 dosages at once so I wont need the second shot.
Narrative:  Medical facility by Ambulance, SOB, Covid Pneumonia, vtach, afib, weakness, fatigue, decreased appetite, CHF, Actinomyces was still mentioned as being possible. Pt was given dex and remdesivir. Patient has been on IV Vancomycin, start date 12/16, and Unasyn. ID consulted, poor dentitian. PT Found decreased 12/26/21
Felt a little bit bad; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING ABNORMAL (Felt a little bit bad) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051F21A, 006M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt a little bit bad). At the time of the report, FEELING ABNORMAL (Felt a little bit bad) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided.  It was reported that HCP felt a little bit bad but not as bad as after second dose.  Treatment information was not provided.   This case was linked to MOD-2022-455277, MOD-2022-455269, MOD-2022-455195, MOD-2022-455207, MOD-2022-455209 (Patient Link).
Passed out after shot, cried it hurt so much, went home, called nurse, she said take Tylenol.  Went to urgent care.  Called Dr again, said keep cold packs on, called nurse again, Dr said hot packs.  Went back to Dr, became ill, hurt so much.  Oct 18th she gave me prescription for codeine, still hurts.  Dr again Oct 18, urgent care.
an 11 year old /on 04-Aug-2021 / received a dose of / Infanrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old patient who received DTPa (Infanrix) (batch number NG5GS, expiry date 26th November 2021) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 4th August 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 4th August 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details provided were as follows: The patient's age at the time of vaccination was not confirmed to be 11 years but reporter commented so. The patient´s chart for an 11 year old showed that, the patient received a dose of Infanrix, which led to inappropriate age at vaccine administration. The reporter consented to follow-up.
This patient had documentation that he received Moderna vaccine but it was found to be an incorrectly documented vaccine. The evidence in reviewing this event found that the patient received a flu vaccine and not Moderna. This is near miss reporting.
This spontaneous report as received from an unspecified reporter refers to a patient of unknown age and gender. The patient's relevant medical history was not reported. On 13-NOV-2014, the patient was vaccinated with a dose of M-M-R II (therapy type, route, dose, frequency and lot # were not reported) which underwent an excursion. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-JUL-2022) and NO ADVERSE EVENT (No adverse event) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-JUL-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-JUL-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-JUL-2022). No concomitant medications were reported.- The vial was initially stored in the refrigerator on 04-Jun-2022.The date of vaccine administration was from 4-Jun-2022 until 26-Jul-2022. The vial did not undergo any temperature excursions. Patient received half dose. No treatment medications were reported.
A report has been received from a Health Professional concerning a 7 year old, female subject, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 22-Jan-2014. The office manager reported that they gave expired FLUMIST QUADRIVALENT (Preferred Term: Expired drug administered) on 22-Jan-2014. No adverse experiences had been reported. The outcome of the event of gave expired FLUMIST QUADRIVALENT in unknown. The report was considered to be non-serious.
SWOLLEN KNEE; PAIN; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure no follow up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced swollen knee, and pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the swollen knee and pain was not reported. This report was non-serious.
Administered vaccine HAVRIX 1 ml IM to left deltoid over 1 min. She got up and within 2 mi, pt stated that she "feels dizzy and seeing black spots." Assisted her back to sitting down on the chair and offered her to lay down on the exam table which she declined. She sat upright and closed her eyes for about 5 more minutes and noticed that she became pale and profusely diaphoretic but remained awake. Assisted her on to the examining table and had her laying flat, elevating her feet and legs by raising the head of the table. Her husband was here and went to get some bottled water. Immediately she began to feel better after laying in that position for about 20 min. Ice pack was given for her forehead which did help. Once she recovered, she sat up for 2 min drinking her bottled water and advised her to move slowly and not to make any sudden movements in the meantime. She was able to ambulate in the room without dizziness or unsteadiness. She felt better and was ok to leave the clinic with her husband.
Prolonged increased heart rate for approximately 18 hours after the shot and perhaps up to 36 hours that included moderate heart stress, feeling of heart inflammation, generic chest heaviness and light/moderate chest/heart pain, as if I had just completed an extreme level of cardio, although I had not done any exercise. The pain/inflammation/chest stress and heavy chest feeling simply emerged within 3-6 hours of the shot, persisted quite steadily for the rest of the day, and slowly subsided the next day. Some moderate headache(s) persisted for a handful of hours. A large, strong general feeling of overall unwellness and crummy mental state persisted for at least 24 hours. I felt compelled to rest in bed during the day for several hours in addition to sleeping early the first night and staying in bed longer the next morning.
About 5 minutes after the vaccination, patient felt generalized pruritis and warmth. There were no respiratory symptoms, abdominal symptoms, no rash, and vital signs stable. patient improved after 5-10 minutes. She was administered diphenhydramine 50 mg IM.
11/13/15 - Unusually tired, started complaining about hands itching before bed. 11/14/15 - Still unusually tired, felt warm wouldn't eat, threw up violently in his sleep at night. Complained about hands itching 11/15/15 - No appetite, but didn't feel sick. Hands still itching. Woke up with a flushed dry rash on face and bottom. 11/16/15  No appetite, hands itching. Woke up stuttering which has never happened before.  11/17/15: Woke up at 4am screaming that his arms and hands hurt and felt "sparkly".  Lasted for over 2 hours and then was terrified to try and go back to sleep.  Still no appetite.  We made him eat dinner and he threw it up.  Still unusually tired, but not able to sleep well. Still stuttering and complain about how it is "hard to talk". Complaining about legs hurting and feeling weird. 11/18/15:  Very tired, but difficulty sleeping. still "hard to talk" and stuttering.  No appetite.
Hospitalization Narrative:  Patient admitted to the hospital for medically supervised alcohol withdrawal. Patient reports no side effects related to vaccination.
Fell; Bruises on both knees; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell) and CONTUSION (Bruises on both knees) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included Walker user and Falling. Concurrent medical conditions included Blood pressure high, Arthritis, Muscle spasms, Cane user, Weakness and Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS), HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, BACLOFEN, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), VITAMIN B3, DULOXETINE and TIZANIDINE for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced FALL (Fell) and CONTUSION (Bruises on both knees). At the time of the report, FALL (Fell) and CONTUSION (Bruises on both knees) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
4/21/03: 2 hours reddened area, small amount erythema. Tx'd with po Benadryl. Continued with Tylenol every 6 hours. Return if Sx worsen. 4/23/03: completely recovered.
her titers in 2019 and had no immunity; This case was reported by a consumer via call center representative and described the occurrence of therapy non-responder in a 35-year-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis and HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received the 1st dose of Engerix B, the 2nd dose of Engerix B and the 3rd dose of Engerix B. On an unknown date, between 1 and 2 years after receiving Engerix B, Engerix B and Engerix B, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.   It was unknown if the reporter considered the therapy non-responder to be related to Engerix B, Engerix B and Engerix B.  Additional information was provided as follows: The caller did not want to provide her complete address. The patient received 3 doses of Engerix B. The patient checked her titers in 2019 and had no immunity, the patient rechecked it again and had no immunity. The patient ended up getting a booster dose in October 2019. The reporter did not consent to follow up. No further details were provided.
No data attached. Per doc 211879, annual follow up, patient still takes chemotherapy to control inflamation and to preserve eyesight. Painful joints and relapses still occur. Also per doc 211879, the anthrax vaccine is responsible for patient auto immune diseases. Patient was very healthy. No indication or past history of symptoms or conditions. The follow up received on 6/27/03 states pt is a 37 year old operating room technician/tattoo artist with incomplete Reiter's syndrome and recurrent scleritis diagosed in August 2000. He had received his 6th anthrax vacciantion on 12/2/99. The pt's syndrome began in April 2000 with the onset of a bilateral inflammatory eye condition throught to be scleritis. He presented to  ER on 4/27/00 with fever and pain of back, neck and jaw. He was admitted to the hospital for further evaluation and was discharged 5/2/00. He again presented to  ER 5/10/00 for two day history of diarrhea, generalized morning soreness/stiffness and migratory arthralgias. The pt was found to have evidence of painless oral ulceration, diffuse arthralgia, and symptoms of apparent tenosynovitis and synovitis involving the hands. Arthralgias were generalized. Treatment included Prednisone, PredForte eye drops, Indomethicin, and Zantac. Additionally, the pt was completing a 1 month trial of Methotrexate as of 9/29/00.